Grid Laser for Diffuse Diabetic Maculopathy

Diabetic Macular Edema Clinical Trial

— MMG  

Official title:

Subthreshold Double Frequency Nd. YAG Grid Laser for Diffuse Diabetic Maculopathy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02555956
• Other study ID #: Macular Grid Laser
• Status: Completed
• Phase: N/A
• First received: August 6, 2015
• Last updated: September 20, 2015
• Start date: April 2012
• Est. completion date: December 2014

Study information

• Verified date: September 2015
• Source: Dow University of Health Sciences
• Contact: n/a
• Is FDA regulated: No
• Health authority: Pakistan: Ministry of Health
• Study type: Observational

Clinical Trial Summary

Diabetic related complications are increasing day by day due to increse in the number of diabetic patients all over the world. Diabetic macular edema is one of them and a major cause of vision imparment. Various kind of treatment modalities are preent to treat this coplication. Grid laser is one treatment modality. Laser phtocoagulation is a destrictive procedure.Laser power if kept to aminimum can get the desired results without severe destruction to the retina . In this study, the investigators are going to document the effect of minimal grid laser tn loss o overcome the visioe to diabetic macular edema.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: December 2014
• Est. primary completion date: December 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 20 Years to 80 Years

Eligibility

Inclusion Criteria:

• Diabetic patients with macular edema.

• both sexes

• conset to participate.

Exclusion Criteria:

• focal edema.

• patients requiring only the focal laser.

• patients with proferative diabetic retinopathy.

• Patients with ischaemic maculopathy on fundus fluorescein angiography.

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Diabetic Macular Edema
• Macular Edema

Locations

Country	Name	City	State
Pakistan	Dow universty Hospital,Dow international Medical college	Karachi	Sindh

Sponsors (1)

Lead Sponsor	Collaborator
Dow University of Health Sciences

Country where clinical trial is conducted

Pakistan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Improvement of visual acuity after grid laser	Visual acuity will be mesured pre laser and 06 weeks post laser	6 week	No
Secondary	Complication	Patiens willbe asked and examined for any potentiail anticipated complication.	during first six weeks after laser	No